News

27. May 2024

Neue Professorin für Molekulare Pharmakologie an der Universität des Saarlandes ab 1. Juni 2024

12.-16. May 2024

Attending the Proteolysis at the membrane – from signaling to disease conference

We are pleased to announce that Daniela Yildiz, Ahmad Aljohmani and Federico Guillermo Gharzia participated in the Proteolysis at the membrane – from signaling to disease conference held in Kloster Seeon, Munich from 12th to 16th of May. This conference brought together experts and scholars from around the world to discuss and share the latest advancements in ectodomain shedding (ADAM, BACE, MMP proteases), intramembrane proteolysis (gamma-secretase, rhomboids, SPPL-proteases, S1P/S2P-proteases, signal-peptidase), protease “modulators” (such as tetraspanins and iRhoms) and inhibitors, substrate biology, proteolytic quality control as well as on therapeutic approaches.

Our participation included Flash talk and two posters with a tittle of “ADAM Proteases: A Pivotal Determinant in the Pathogenesis of Infectious Diseases” For Ahmad and “Ca2+-threshold dependency and spatial determination of ADAM10’s activation” for Federico.

We look forward to applying the insights gained from this conference to our ongoing work and contributing further to the field.

© D. Yildiz

April 2024

Congratulations to Ahmad Aljohmani

We are thrilled to announce that Ahmad Aljohmani has successfully defended his PhD thesis, earning a summa cum laude distinction. This is a remarkable achievement and a testament to his hard work, dedication, and scholarly excellence.

 

 
© D. Yildiz

March 2024

Poster prize at the 9th German Pharma-Tox summit

Poster prize at the 9th German Pharma-Tox summit

Ahmad Aljohmani won the best poster prize at the 9th German Pharm-Tox Summit in Munich for his work on ADAM proteases as a therapeutic and prognostic target. The poster was titled “The emerging roles of the proteolytic and non-proteolytic activity of ADAM proteases as a therapeutic and prognostic target in infectious diseases”.

The department extends its warmest congratulations.

 

Funding

DFG Gewebespezifische Rolle von ADAM-Proteasen in infektiösen Lungenerkrankungen

DFG YI 176/1-1 (DR 1013/1-1)

BMBF 16LW0140K

DataPin